BMH BRÄUTIGAM advises Apryl on € 4.1 million seed financing round
BMH BRÄUTIGAM has advised Europe´s first fertility and family forming benefits platform Apryl in a € 4.1 million seed funding round.
The round is led by Breega. In addition, Atlantic Labs (lead investor in the pre seed round), Crista Galli Ventures, Myelin VC, Alliance For Impact Ventures (a Ventech fund) and Westtech Ventures also participated in the financing round to help fuel Apryl’s next phase of growth.
Apryl (formerly known as Oviavo) is a Berlin-based fertility and family forming benefits platform founded in 2019 by Jenny Saft and Tobias Kaufhold. Since people are now having children much later in life and fertility rates are continuing to decline with age, Apryl believes that in the long run, a large percentage of the professional population will need support with reproductive treatments. With their platform, the two founders want to enable companies to support employees on their path to become parents in a secure and confidential manner.
Background: In addition to investors, BMH BRÄUTIGAM also regularly advises emerging startups during the founding phase and in subsequent financing rounds. After the financing round, we look forward to continuing to accompany Apryl on its growth course.
Team BMH BRÄUTIGAM: Dr. Alexander Wulff, Lisa-Marie Sarucco (both Venture Capital)